Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
22%
Ph phase_2
3
33%
Ph phase_4
1
11%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(4)
Other(1)

Detailed Status

Completed4
Not yet recruiting2
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (42.9%)
Phase 31 (14.3%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

completed444%
unknown111%
not_yet_recruiting222%
recruiting222%

Recent Activity

2 active trials
Showing 5 of 9
not_yet_recruitingnot_applicable

Low-dose Colchicine for CABG Graft Failure Prevention

NCT07569328
recruitingphase_3

Colchicine Versus Placebo in Acute Myocarditis Patients

NCT05855746
not_yet_recruitingphase_2

Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment

NCT06855433
completedphase_2

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage

NCT05159219
recruitingnot_applicable

Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

NCT06215989
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07569328Not Applicable

Low-dose Colchicine for CABG Graft Failure Prevention

Not Yet Recruiting
NCT05855746Phase 3

Colchicine Versus Placebo in Acute Myocarditis Patients

Recruiting
NCT06855433Phase 2

Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment

Not Yet Recruiting
NCT05159219Phase 2

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage

Completed
NCT06215989Not Applicable

Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

Recruiting
NCT03874338

CLEAR SYNERGY Neutrophil Substudy

Completed
NCT04224545Phase 4

COlchicine in Cardiac Surgery

Completed
NCT05745818

Colchicine for Reduction of Periprocedural Myocardial Injury in Percutaneous Coronary Intervention

Unknown
NCT04359095Phase 2

Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9